Skip to main content

Table 1 Patient characteristics at baseline

From: Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial

Characteristic Experimental group (N = 80) Control group (N = 80) Statistics P
Age (years) 59.70 ± 8.12 59.33 ± 9.66 t = 0.275 0.784
Sex    χ2 = 0.040 0.841
 Male 64 65   
 Female 16 15   
Smoking history    χ2 = 0.417 0.519
 Smoker 50 46   
 Never smoker 30 34   
Stage    χ2 = 0.740 0.786
 Extensive stage 7 8   
 Limited stage 73 72